Charles S. Harmon

2.6k total citations
50 papers, 2.1k citations indexed

About

Charles S. Harmon is a scholar working on Molecular Biology, Urology and Dermatology. According to data from OpenAlex, Charles S. Harmon has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Urology and 10 papers in Dermatology. Recurrent topics in Charles S. Harmon's work include Hair Growth and Disorders (12 papers), Renal cell carcinoma treatment (5 papers) and Wound Healing and Treatments (5 papers). Charles S. Harmon is often cited by papers focused on Hair Growth and Disorders (12 papers), Renal cell carcinoma treatment (5 papers) and Wound Healing and Treatments (5 papers). Charles S. Harmon collaborates with scholars based in United States, Switzerland and United Kingdom. Charles S. Harmon's co-authors include Thomas D. Nevins, Samuel E. DePrimo, Thomas E. Hutson, George D. Demetri, Sindy T. Kim, M. Dror Michaelson, Vanessa Tassell, Paolo G. Casali, Jean‐Yves Blay and Isan Chen and has published in prestigious journals such as Journal of Clinical Oncology, Circulation Research and Biochemical Journal.

In The Last Decade

Charles S. Harmon

47 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles S. Harmon United States	22	768	735	422	324	288	50	2.1k
Kazuyuki Ishida Japan	33	799 1.0×	795 1.1×	1.1k 2.5×	389 1.2×	122 0.4×	190	3.4k
Carsten Boltze Germany	29	750 1.0×	893 1.2×	532 1.3×	335 1.0×	335 1.2×	87	2.7k
Wei-Shone Chen Taiwan	33	1.1k 1.4×	708 1.0×	1.7k 4.1×	632 2.0×	23 0.1×	106	3.1k
Masahide Ikeguchi Japan	40	1.4k 1.9×	1.8k 2.4×	1.7k 4.0×	470 1.5×	673 2.3×	198	4.6k
Wei Ding China	22	935 1.2×	379 0.5×	323 0.8×	198 0.6×	42 0.1×	66	1.6k
Zhen Liu China	20	661 0.9×	327 0.4×	407 1.0×	295 0.9×	201 0.7×	86	1.5k
Jinping Lai United States	24	856 1.1×	243 0.3×	516 1.2×	303 0.9×	36 0.1×	108	2.5k
I Miyazaki Japan	29	613 0.8×	794 1.1×	1.2k 2.9×	545 1.7×	295 1.0×	148	2.8k
Hironaka Kawasaki Japan	30	701 0.9×	162 0.2×	376 0.9×	283 0.9×	35 0.1×	120	2.7k
Isao Shirato Japan	29	833 1.1×	203 0.3×	152 0.4×	133 0.4×	38 0.1×	101	2.8k

Countries citing papers authored by Charles S. Harmon

Since Specialization

Citations

This map shows the geographic impact of Charles S. Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Harmon more than expected).

Fields of papers citing papers by Charles S. Harmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Harmon. The network helps show where Charles S. Harmon may publish in the future.

Co-authorship network of co-authors of Charles S. Harmon

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Harmon. A scholar is included among the top collaborators of Charles S. Harmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Harmon. Charles S. Harmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Draper, Nicole L., Laura Connelly‐Smith, Caroline R. Alquist, et al.. (2025). Poor Mobilization and Plerixafor Use in Matched Related Peripheral Hematopoietic Progenitor Cell Donors. Journal of Clinical Apheresis. 40(6). e70074–e70074.

Zurita, Amado J., Mehrdad Khajavi, L. Tye, et al.. (2015). Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours. British Journal of Cancer. 112(7). 1199–1205. 36 indexed citations

Groen, Harry J.M., Mark A. Socinski, Francesco Grossi, et al.. (2013). A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC). Annals of Oncology. 24(9). 2382–2389. 47 indexed citations

Harmon, Charles S., Samuel E. DePrimo, Robert A. Figlin, et al.. (2013). Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma. Cancer Chemotherapy and Pharmacology. 73(1). 151–161. 47 indexed citations

Demetri, George D., Patrick Schöffski, Manisha H. Shah, et al.. (2012). Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure. Clinical Cancer Research. 18(11). 3170–3179. 102 indexed citations

DePrimo, Samuel E., Xin Huang, Martin E. Blackstein, et al.. (2009). Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure. Clinical Cancer Research. 15(18). 5869–5877. 38 indexed citations

Rini, Brian I., M. Dror Michaelson, Jonathan E. Rosenberg, et al.. (2008). Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 26(22). 3743–3748. 321 indexed citations

George, Suzanne, Jean‐Yves Blay, Paolo G. Casali, et al.. (2008). Continuous daily dosing (CDD) of sunitinib (SU) in pts with advanced GIST: Updated efficacy, safety, PK and pharmacodynamic analysis. Journal of Clinical Oncology. 26(15_suppl). 10554–10554. 14 indexed citations

Harmon, Charles S., Thomas D. Nevins, & Wendy B. Bollag. (2006). Protein kinase C inhibits human hair follicle growth and hair fibre production in organ culture. British Journal of Dermatology. 133(5). 686–693. 9 indexed citations

10.

Chen, Guan, et al.. (1998). Protection against cyclophosphamide-induced alopecia and inhibition of mammary tumor growth by topical 1,25-dihydroxyvitamin D3 in mice. International Journal of Cancer. 75(2). 303–309. 19 indexed citations

11.

Harmon, Charles S., et al.. (1997). Bisindolylmaleimide Protein-Kinase-C Inhibitors Delay the Decline in DNA Synthesis in Mouse Hair Follicle Organ Cultures. Skin Pharmacology and Physiology. 10(2). 71–78. 10 indexed citations

12.

Xiong, Yimin & Charles S. Harmon. (1997). Interleukin-1β Is Differentially Expressed by Human Dermal Papilla Cells in Response to PKC Activation and Is a Potent Inhibitor of Human Hair Follicle Growth in Organ Culture. Journal of Interferon & Cytokine Research. 17(3). 151–157. 34 indexed citations

13.

Xiong, Yimin & Charles S. Harmon. (1995). Evidence that Diazoxide Promotes Calcium Influx in Mouse Keratinocyte Cultures by Membrane Hyperpolarization. Skin Pharmacology and Physiology. 8(6). 309–318. 9 indexed citations

14.

Bollag, Wendy B., et al.. (1995). Biphasic effect of 1,25‐dihydroxyvitamin D³ on primary mouse epidermal keratinocyte proliferation. Journal of Cellular Physiology. 163(2). 248–256. 36 indexed citations

15.

Harmon, Charles S. & Thomas D. Nevins. (1994). Biphasic Effect of 1,25-Dihydroxyvitamin D3 on Human Hair Follicle Growth and Hair Fiber Production in Whole-Organ Cultures. Journal of Investigative Dermatology. 103(3). 318–322. 22 indexed citations

16.

Harmon, Charles S. & Thomas D. Nevins. (1994). Hair fibre production by human hair follicles in whole-organ culture. British Journal of Dermatology. 130(4). 415–423. 16 indexed citations

17.

Bollag, Wendy B., et al.. (1993). Effects of the Selective Protein Kinase C Inhibitor, Ro 31-7549, on the Proliferation of Cultured Mouse Epidermal Keratinocytes. Journal of Investigative Dermatology. 100(3). 240–246. 25 indexed citations

18.

Harmon, Charles S., et al.. (1993). Potassium Channel Openers Stimulate DNA Synthesis in Mouse Epidermal Keratinocyte and Whole Hair Follicle Cultures. Skin Pharmacology and Physiology. 6(3). 170–178. 26 indexed citations

19.

Mak, Vivien H. W., et al.. (1991). Barrier Function of Human Keratinocyte Cultures Grown at the Air-Liquid Interface. Journal of Investigative Dermatology. 96(3). 323–327. 91 indexed citations

20.

Harmon, Charles S., et al.. (1989). The Water Permeability of Primary Mouse Keratinocyte Cultures Grown at The Air-Liquid Interface. Journal of Investigative Dermatology. 92(4). 598–600. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact